Birmingham, West Midlands -- (SBWIRE) -- 12/19/2013 -- Value Penny Stocks issues special report on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), ProShares Trust UltraPro Short QQQ ETF (NASDAQ:SQQQ), Delcath Systems, Inc. (NASDAQ:DCTH), Avanir Pharmaceuticals Inc (NASDAQ:AVNR).
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) ended its recent business day with the gain of 1.09% and closed at the price of $5.58 after opening at $5.54. The stock traded during its last trading session with the total volume of 4,106,077 shares, as compared to its average volume of 5.55 million shares. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
For How Long ARNA will Fight for Profitability? Read This Trend Analysis report
ProShares Trust UltraPro Short QQQ ETF (NASDAQ:SQQQ) remained among the day decliners and traded with volume of 4,055,206 shares in the last session, as compared to average volume of 2.08 million shares. In comparison with 52 week range of $15.27 - $43.71, it faced lowest price of $15.40 during the last trading session whereas its day highest price was $16.63. The company’s total market capitalization is $194.16 billion. The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ-100 IndexÂ®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as three times the inverse (-3x) of the daily return of the index.
Has SQQQ Found The Bottom And Ready To Gain Momentum? Find Out Here
Delcath Systems, Inc. (NASDAQ:DCTH) showed 3,783,556 shares in volume during the last trading session, while the average trading volume remained 1.56 million shares. The stock kicked off its trading session at $0.25 and closed at $0.235 after declining -6.00%. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. The company’s proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents.
Why Should Investors Buy DCTH After the Recent Fall? Just Go Here and Find Out
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock traded during its last trading session with the total traded volume of 3,783,533 shares versus its average volume of 2.54 million shares. The company opened its trade at the price of $2.67 and its closing price was $2.65 after losing -1.12% for the day. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)